C McNeil Selected Research

Therapeutics

12/2016	Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
12/2000	Consensus panel endorses range of adjuvant therapies for breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C McNeil Research Topics

Disease

3	Neoplasms (Cancer) 12/2016 - 06/2001
2	Melanoma (Melanoma, Malignant) 12/2016 - 06/2014
1	Death (Near-Death Experience) 12/2016
1	Adenocarcinoma 06/2014
1	Fatigue 06/2001
1	Breast Neoplasms (Breast Cancer) 12/2000
1	Oropharyngeal Neoplasms 05/2000

Drug/Important Bio-Agent (IBA)

1	pembrolizumabIBA 12/2016
1	VemurafenibIBA 06/2014
1	Tyrosine Kinase InhibitorsIBA 06/2014
1	Pharmaceutical PreparationsIBA 06/2001
1	VaccinesIBA 05/2000

Therapy/Procedure

2	Therapeutics 12/2016 - 12/2000
1	Immunotherapy 12/2016